p53 Staining Correlates With Tumor Type and Location in Sebaceous Neoplasms

被引:36
|
作者
Shalin, Sara C. [3 ]
Sakharpe, Aniket [4 ]
Lyle, Stephen [5 ]
Lev, Dina [4 ]
Calonje, Eduardo [6 ]
Lazar, Alexander J. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Sect Dermatopathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[5] Univ Massachusetts, Med Ctr, Dept Canc Biol, Worcester, MA USA
[6] St Thomas Hosp, St Johns Inst Dermatol, London, England
基金
美国国家卫生研究院;
关键词
sebaceous adenoma; sebaceoma; sebaceous carcinoma; p53; Muir-Torre syndrome; DNA mismatch repair; microsatellite instability; MUIR-TORRE-SYNDROME; DNA MISMATCH REPAIR; CELL CARCINOMA; MSH2; MUTATIONS; EXPRESSION; BASAL; DIFFERENTIATION; PHENOTYPE; PROTEINS; ADJACENT;
D O I
10.1097/DAD.0b013e3181ed39f9
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Sebaceous neoplasms are commonly considered in their relationship to the Muir-Torre syndrome and the now well-documented loss of DNA mismatch repair proteins leading to microsatellite instability. However, sebaceous neoplasms showing microsatellite instability comprise only a subset of this group of tumors, and thus, alternative tumorigenic mechanisms must exist. This article explores the relationship of p53, a tumor suppressor implicated in other cutaneous malignancies, and sebaceous neoplasia. We examined 94 sebaceous tumors from 92 patients. Tumors with strong nuclear p53 staining were significantly associated with the diagnosis of sebaceous carcinoma compared with benign sebaceous lesions, most notably for periocular carcinomas. Importantly, nuclear mismatch repair protein expression was intact in all lesions showing p53 alterations, suggesting that p53 dysfunction may represent a divergent pathway in the molecular pathogenesis of these tumors.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 50 条
  • [21] P53 staining index and zonal staining patterns in actinic keratoses
    Javor, Sanja
    Gasparini, Giulia
    Biatta, Chiara Maria
    Cozzani, Emanuele
    Cabiddu, Francesco
    Ravetti, Jean Louis
    Vellone, Valerio Gaetano
    Parodi, Aurora
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2021, 313 (04) : 275 - 279
  • [22] P53 NUCLEAR-PROTEIN ACCUMULATION CORRELATES WITH MUTATIONS IN THE P53 GENE, TUMOR GRADE, AND STAGE IN BLADDER-CANCER
    ESRIG, D
    SPRUCK, CH
    NICHOLS, PW
    CHAIWUN, B
    STEVEN, K
    GROSHEN, S
    CHEN, SC
    SKINNER, DG
    JONES, PA
    COTE, RJ
    AMERICAN JOURNAL OF PATHOLOGY, 1993, 143 (05): : 1389 - 1397
  • [23] Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
    Wu, Jianyuan
    Li, Qingdi Quentin
    Zhou, Huiping
    Lu, Yinying
    Li, Jueli M.
    Ma, Yao
    Wang, Li
    Fu, Tingting
    Gong, Xingjiang
    Weintraub, Michael
    Wu, Shuangchan
    Ding, Hong
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [24] ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
    WesierskaGadek, J
    BugajskaSchretter, A
    Cerni, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (01) : 90 - 101
  • [25] Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression
    Gogna, Rajan
    Madan, Esha
    Kuppusamy, Periannan
    Pati, Uttam
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2907 - 2914
  • [26] Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
    Jianyuan Wu
    Qingdi Quentin Li
    Huiping Zhou
    Yinying Lu
    Jueli M. Li
    Yao Ma
    Li Wang
    Tingting Fu
    Xingjiang Gong
    Michael Weintraub
    Shuangchan Wu
    Hong Ding
    Medical Oncology, 2014, 31
  • [27] Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    Loging, WT
    Reisman, D
    ONCOGENE, 1999, 18 (52) : 7608 - 7615
  • [28] Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    W Troy Loging
    David Reisman
    Oncogene, 1999, 18 : 7608 - 7615
  • [29] p53 immunohistochemical staining and correlation with TP53 status
    Viana-Errasti, J.
    Martinez Aracil, A. P.
    Jimenez, K.
    Pereda, A.
    Perez de Nanclares, G.
    Aguirre, J. J.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S137 - S138
  • [30] p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
    V. Marcel
    P. Hainaut
    Cellular and Molecular Life Sciences, 2009, 66